Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07596173
- Conditions
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Locations
-
- GSK Investigational Site Fukuoka, Japan
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Hokkaido, Japan
NCT07596199
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
- Locations
-
- GSK Investigational Site Chiba, Japan
- GSK Investigational Site Fukui, Japan
- GSK Investigational Site Fukushima, Japan
- GSK Investigational Site Hokkaido, Japan
NCT04082299
- Conditions
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Locations
-
- Hillel Yaffe medical center Hadera, Israel
NCT02569879
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Aspergillosis, +23 more
- Locations
-
- GSK Investigational Site Bogotá, Colombia
NCT01568060
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +25 more
- Locations
-
- GSK Investigational Site Seoul, South Korea
NCT03311659
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
- Locations
-
- GSK Investigational Site Barnaul, Russia
- GSK Investigational Site Gatchina, Russia
- GSK Investigational Site Moscow, Russia
- GSK Investigational Site Moscow, Russia
NCT02377349
- Conditions
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Fitzroy, Victoria, Australia
- GSK Investigational Site Parkville, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT01929291
- Conditions
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Locations
-
- GSK Investigational Site Suwon, South Korea